1. Home
  2. ABM vs NAMS Comparison

ABM vs NAMS Comparison

Compare ABM & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABM
  • NAMS
  • Stock Information
  • Founded
  • ABM 1909
  • NAMS 2019
  • Country
  • ABM United States
  • NAMS Netherlands
  • Employees
  • ABM N/A
  • NAMS N/A
  • Industry
  • ABM Diversified Commercial Services
  • NAMS Biotechnology: Pharmaceutical Preparations
  • Sector
  • ABM Finance
  • NAMS Health Care
  • Exchange
  • ABM Nasdaq
  • NAMS Nasdaq
  • Market Cap
  • ABM 2.8B
  • NAMS 3.1B
  • IPO Year
  • ABM N/A
  • NAMS N/A
  • Fundamental
  • Price
  • ABM $43.07
  • NAMS $41.22
  • Analyst Decision
  • ABM Strong Buy
  • NAMS Strong Buy
  • Analyst Count
  • ABM 3
  • NAMS 10
  • Target Price
  • ABM $55.67
  • NAMS $44.80
  • AVG Volume (30 Days)
  • ABM 525.0K
  • NAMS 1.0M
  • Earning Date
  • ABM 12-17-2025
  • NAMS 11-05-2025
  • Dividend Yield
  • ABM 2.47%
  • NAMS N/A
  • EPS Growth
  • ABM N/A
  • NAMS N/A
  • EPS
  • ABM 1.84
  • NAMS N/A
  • Revenue
  • ABM $8,627,900,000.00
  • NAMS $35,243,000.00
  • Revenue This Year
  • ABM $5.43
  • NAMS N/A
  • Revenue Next Year
  • ABM $3.15
  • NAMS N/A
  • P/E Ratio
  • ABM $23.31
  • NAMS N/A
  • Revenue Growth
  • ABM 4.27
  • NAMS 4.91
  • 52 Week Low
  • ABM $40.00
  • NAMS $14.06
  • 52 Week High
  • ABM $57.93
  • NAMS $42.00
  • Technical
  • Relative Strength Index (RSI)
  • ABM 50.66
  • NAMS 63.40
  • Support Level
  • ABM $41.56
  • NAMS $36.59
  • Resistance Level
  • ABM $43.52
  • NAMS $42.00
  • Average True Range (ATR)
  • ABM 0.89
  • NAMS 2.48
  • MACD
  • ABM 0.28
  • NAMS 0.10
  • Stochastic Oscillator
  • ABM 84.80
  • NAMS 88.27

About ABM ABM Industries Incorporated

ABM Industries Inc is a provider of integrated facility solutions. It offers its solutions through five segments: Business and Industry, Manufacturing and Distribution, Education, Aviation and Technical solutions. The company derives the majority of its revenue from the business and industry segment, which encompasses janitorial, facilities engineering, and parking services for commercial real estate properties and sports and entertainment venues, hospitals, as well as vehicle maintenance and other services to rental car providers. The company mainly operates in the United States of America.

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

Share on Social Networks: